The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Serotonin, the periaqueductal gray and panic
Abstract
This article reviews experimental evidence and theoretical constructs that implicate serotonin (5-HT) modulation of defensive behavior within the midbrain periaqueductal gray in panic disorder (PD). Evidence with conflict tests in experimental animals indicates that 5-HT enhances anxiety, whereas results with aversive stimulation of the dorsal periaqueductal gray point to an anxiolytic role of 5-HT. To solve this contradiction, it has been suggested that the emotional states determined by the two types of animal model are different. Conflict tests would generate conditioned anxiety, whereas periaqueductal gray stimulation would produce unconditioned fear, as evoked by proximal threat. Clinically, the former would be related to generalized anxiety while the latter to PD. Thus, 5-HT is supposed to facilitate anxiety, but to inhibit panic. This hypothesis has been tested in the animal model of anxiety and panic named the elevated T-maze, in two procedures of human experimental anxiety applied to healthy volunteers or panic patients, and in CO2-induced panic attacks. Overall, the obtained results have shown that drugs that enhance 5-HT function increase different indexes of anxiety, but decrease indexes of panic. Drugs that impair 5-HT function have the opposite effects. Thus, so far the predictions derived from the above hypothesis have been fulfilled.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“pointing toward differences in fear and panic responses between susceptible and resilient mice (43,44,59).”
From Neuroanatomic differences associated with stress susceptibility and resilience (2016) · cites this paper as [59]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,603
Diagnostic and Statistical Manual of Mental Disorders, 3rd ed
Cooper, A. M., & Michels, R. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.1.128 · Cited by 7,419
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Drake, M. M. (1988) · American Journal of Occupational Therapy · doi:10.5014/ajot.42.10.683b · Cited by 5,303
A Syndrome produced by Diverse Nocuous Agents
Selye, H. (1936) · Nature · doi:10.1038/138032a0 · Cited by 3,967
Learned helplessness: Theory and evidence
Maier, S. F., & Seligman, M. E. (1976) · Journal of Experimental Psychology: General · doi:10.1037/0096-3445.105.1.3 · Cited by 2,494
The role of the amygdala in fear and anxiety
Davis, M. (1992) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.15.030192.002033 · Cited by 2,357
The Neuropsychology of Anxiety
Gray, J. A., & McNaughton, N. (2003) · doi:10.1093/acprof:oso/9780198522713.001.0001 · Cited by 1,953
Azmitia, E. C., & Segal, M. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901790311 · Cited by 1,908
Diagnostic and Statistical Manual of Mental Disorders
Preedy, V., & Watson, R. (2010) · Springer eBooks · doi:10.1007/978-0-387-78665-0_5485 · Cited by 1,146
5-HT and mechanisms of defence
Deakin, J. F. W., & Graeff, F. G. (1991) · Journal of Psychopharmacology · doi:10.1177/026988119100500414 · Cited by 1,011
Self-citationNeuroanatomical Hypothesis of Panic Disorder, Revised
Gorman, J. M., KENT, J. M., Sullivan, G. M., & Coplan, J. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.493 · Cited by 998
Role of 5-HT in stress, anxiety, and depression
Graeff, F. G., Guimarães, F. S., De Andrade, T. G. C. S., & Deakin, J. F. W. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02135-3 · Cited by 984
Self-citationHandley, S. L., & Mithani, S. (1984) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00504983 · Cited by 974
Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult
Gross, C. T., Zhuang, X., Stark, K. L., Ramboz, S., Oosting, R. S., Kirby, L. G., Santarelli, L., Beck, S. G., & Hen, R. (2002) · Nature · doi:10.1038/416396a · Cited by 906
Delineation of two drug-responsive anxiety syndromes
Klein, D. F. (1964) · Psychopharmacologia · doi:10.1007/bf02193476 · Cited by 898
Emotional memory systems in the brain
LeDoux, J. E. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90091-4 · Cited by 812
THE EMERGENCY FUNCTION OF THE ADRENAL MEDULLA IN PAIN AND THE MAJOR EMOTIONS
Cannon, W. (1914) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1914.33.2.356 · Cited by 644
Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action
Piñeyro, G., & Blier, P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01417-0 · Cited by 537
Griebel, G. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)98597-j · Cited by 487
Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic
Blanchard, D. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00009-4 · Cited by 461
The neuropsychology of anxiety
LADER, M. H. (1983) · Personality and Individual Differences · doi:10.1016/0191-8869(83)90137-x · Cited by 418
The Midbrain Periaqueductal Gray as a Coordinator of Action in Response to Fear and Anxiety
Fanselow, M. S. (1991) · Springer eBooks · doi:10.1007/978-1-4615-3302-3_10 · Cited by 408
Defensive behaviors of laboratory and wild Rattus norvegicus..
Blanchard, R. J., Flannelly, K. J., & Blanchard, D. C. (1986) · Journal of comparative psychology · doi:10.1037/0735-7036.100.2.101 · Cited by 405
The elevated T-maze as an experimental model of anxiety
Graeff, F. G., Netto, C. F., & Zangrossi, H. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00024-4 · Cited by 393
Self-citationThe action of sedatives on brain stem oculomotor systems in man
Norris, H. (1971) · Neuropharmacology · doi:10.1016/0028-3908(71)90039-6 · Cited by 384
Lactate Provocation of Panic Attacks
Liebowitz, M. R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790300077010 · Cited by 376
Blanchard, D. C., Hynd, A. L., Minke, K. A., Minemoto, T., & Blanchard, R. J. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00056-2 · Cited by 346
Davis, M. (1986) · Behavioral Neuroscience · doi:10.1037//0735-7044.100.6.814 · Cited by 345
Benzodiazepines: Anxiety-Reducing Activity by Reduction of Serotonin Turnover in the Brain
Wise, C. D., Berger, B. D., & Stein, L. (1972) · Science · doi:10.1126/science.177.4044.180 · Cited by 340
Neuroanatomical correlates of a lactate-induced anxiety attack.
Reiman, E., Raichle, M., Robins, E., Mintun, M., Fusselman, M. J., Fox, P. T., Price, J., & Hackman, K. A. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810060013003 · Cited by 319
Role of the amygdala and periaqueductal gray in anxiety and panic.
Graeff, F. G., Silveira, M. C. L., Nogueira, R. L., Audi, E. A., & Oliveira, R. M. W. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90097-a · Cited by 301
Self-citationThe application of positron emission tomography to the study of panic disorder
Reiman, E. M., Raichle, M. E., Robins, E., Butler, F. K., Herscovitch, P., Fox, P. T., & Perlmutter, J. S. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.4.469 · Cited by 290
Textbook of Biological Psychiatry
(2003) · Wiley eBooks · doi:10.1002/0471468975 · Cited by 281
Davis, M. T. (1986) · Behavioral Neuroscience · doi:10.1037/0735-7044.100.6.814 · Cited by 265
Stein, M. B. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020087010 · Cited by 259
Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei
Adell, A., Celada, P., Abellán, M. T., & Artigas, F. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00182-0 · Cited by 254
Learning Motivated by Electrical Stimulation of the Brain
Delgado, J. M. R., Roberts, W. W., & Miller, N. E. (1954) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1954.179.3.587 · Cited by 251
Learning Motivated by Electrical Stimulation of the Brain
Delgado, J. M. R., & Roberts, W. W. (2017) · Routledge eBooks · doi:10.4324/9780203787410-23 · Cited by 251
The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam.
Graeff, F. G., Viana, M. D. B., & Tomaz, C. A. B. (1993) · PubMed · Cited by 245
Self-citationHodges, H., Green, S., & Glenn, B. (1987) · Psychopharmacology · doi:10.1007/bf00176484 · Cited by 242
Behavioral Effects of Acute and Chronic Imipramine in the Elevated T-Maze Model of Anxiety
Teixeira, R. C., Zangrossi, H., & Graeff, F. G. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00261-0 · Cited by 238
Self-citationHsieh, J.-C., Stone-Elander, S., & Ingvar, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00060-9 · Cited by 238
International Symposium on Pain
Bonica, J. J. E. (1974) · Cited by 235
Schenberg, L. C., Bittencourt, A. S., Sudré, E. C. M., & Vargas, L. C. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00060-4 · Cited by 232
Ceulemans, D., Hoppenbrouwers, M., Gelders, Y. G., & Reyntjens, A. J. M. (1985) · Pharmacopsychiatry · doi:10.1055/s-2007-1017385 · Cited by 226
On serotonin and experimental anxiety
Graeff, F. G. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1112-4 · Cited by 219
Self-citationde Molina, A. F., & Hunsperger, R. W. (1959) · The Journal of Physiology · doi:10.1113/jphysiol.1959.sp006140 · Cited by 217
Fenfluramine provocation of anxiety in patients with panic disorder
Targum, S. D., & Marshall, L. E. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90210-2 · Cited by 198
Dual role of 5-HT in defense and anxiety
Graeff, F. G., Viana, M. D. B., & Mora, P. O. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00059-0 · Cited by 195
Self-citationden Boer, J. A., & Westenberg, H. G. M. (1990) · Psychopharmacology · doi:10.1007/bf02245749 · Cited by 195
Woods, S. W. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800160077010 · Cited by 184
Maier, S. F., Grahn, R. E., Kalman, B. A., Sutton, L. C., Wiertelak, E. P., & Watkins, L. R. (1993) · Behavioral Neuroscience · doi:10.1037//0735-7044.107.2.377 · Cited by 177
Behavioral Validation of the Elevated T-Maze, a New Animal Model of Anxiety
Zangrossi, H., & Graeff, F. G. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(96)00381-4 · Cited by 172
Self-citationAntipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze
Poltronieri, S. C., Zangrossi, H., & Viana, M. D. B. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00151-7 · Cited by 170
Maier, S. F., Grahn, R. E., & Watkins, L. R. (1995) · Behavioral Neuroscience · doi:10.1037//0735-7044.109.3.404 · Cited by 167
Tyrer, P. J. (1988) · Oxford University Press eBooks · Cited by 166
Anti-aversive role of serotonin in the dorsal periaqueductal grey matter
Schütz, M. T. B., Aguiar, J. C. D., & Graeff, F. G. (1985) · Psychopharmacology · doi:10.1007/bf00428199 · Cited by 160
Self-citationBriley, M. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb06593.x · Cited by 156
Neurobiology of panic disorder
Bourin, M., Baker, G. B., & Bradwejn, J. (1998) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(97)00203-1 · Cited by 155
Bhatnagar, S., Viau, V., Chu, A., Soriano, L., Meijer, O. C., & Dallman, M. F. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-14-05564.2000 · Cited by 152
Endocrine and physiological changes during “spontaneous” panic attacks
Cameron, O. G., Lee, M. A., Curtis, G. C., & McCann, D. S. (1987) · Psychoneuroendocrinology · doi:10.1016/0306-4530(87)90061-8 · Cited by 152
Potentiated startle: Its relation to freezing and shock intensity in rats.
Leaton, R. N., & Borszcz, G. S. (1985) · Journal of Experimental Psychology Animal Behavior Processes · doi:10.1037/0097-7403.11.3.421 · Cited by 151
Multiple serotonin mechanisms in animal models of anxiety
Handley, S. L., McBlane, J. W., Critchley, M. A. E., & Njung'e, K. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90104-x · Cited by 150
Neural Correlates of Competing Fear Behaviors Evoked by an Innately Aversive Stimulus
Mongeau, R., Miller, G. A., Chiang, E., & Anderson, D. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03855.2003 · Cited by 142
Simulated public speaking as a model of clinical anxiety
McNair, D. M., Frankenthaler, L. M., Czerlinsky, T., White, T. W., Sasson, S., & Fisher, S. (1982) · Psychopharmacology · doi:10.1007/bf00436092 · Cited by 140
Javanmard, M., Shlik, J., Kennedy, S. H., Vaccarino, F. J., Houle, S., & Bradwejn, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00348-5 · Cited by 138
The psychobiology of anxiolytic drugs
Sandford, J. J., Argyropoulos, S. V., & Nutt, D. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00082-6 · Cited by 137
Maier, S. F., Grahn, R. E., Kalman, B. A., et al. (1993) · Behavioral Neuroscience · doi:10.1037/0735-7044.107.2.377 · Cited by 134
Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion
Nogueira, R. L., & Graeff, F. G. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00402-5 · Cited by 132
Self-citationBehavioral Pharmacology of 5-ht
Bevan, P., & Bevan, P. (2013) · Psychology Press eBooks · doi:10.4324/9780203771310 · Cited by 131
Vianna, D. M. L., Landeira-Fernández, J., & Brandão, M. L. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00052-5 · Cited by 129
Temporal lobe volume in panic disorder — a quantitative magnetic resonance imaging study
Vythilingam, M., Anderson, E., Goddard, A. W., Woods, S. W., Staib, L. H., Charney, D. S., & Bremner, J. D. (2000) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(00)00055-x · Cited by 128
Role of the periaqueductal gray substance in the antianxiety action of benzodiazepines
Schenberg, L. C., & Graeff, F. G. (1978) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(78)90287-3 · Cited by 124
Self-citationMonoaminergic mechanisms in aversive brain stimulation
Kiser, R. S., & Lebovitz, R. M. (1975) · Physiology & Behavior · doi:10.1016/0031-9384(75)90278-4 · Cited by 123
The psychobiology of anxiolytic drugs
Argyropoulos, S. V., Sandford, J. J., & Nutt, D. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00083-8 · Cited by 117
Minor tranquilizers and brain defense systems.
Graeff, F. G. (1981) · PubMed · Cited by 115
Self-citationVianna, D. M. L., Graeff, F. G., Brandão, M. L., & Landeira-Fernandez, J. (2001) · Neuroreport · doi:10.1097/00001756-200112210-00049 · Cited by 114
Self-citationEffects of ritanserin on aversive classical conditioning in humans
Hensman, R., Guimarães, F. S., Wang, M., & Deakin, J. F. W. (1991) · Psychopharmacology · doi:10.1007/bf02244182 · Cited by 112
Effect of chlorimipramine and maprotiline on experimental anxiety in humans
Guimarães, F. S., Zuardi, A. W., & Graeff, F. G. (1987) · Journal of Psychopharmacology · doi:10.1177/026988118700100305 · Cited by 110
Self-citationPharmacology and neurochemistry of nefazodone, a novel antidepressant drug.
Dp, T., Carter, R. B., As, E., Mullins, U. L., Smith, H. L., Torrente, J. R., Rn, W., & Yocca, F. D. (1995) · PubMed · Cited by 108
Vianna, D. M. L., Graeff, F. G., Landeira-Fernández, J., & Brandão, M. L. (2001) · Learning & Memory · doi:10.1101/lm.36101 · Cited by 102
Self-citationAnimal Models of Anxiety Disorders
Graeff, F. G., & Zangrossi, H. (2002) · Biological Psychiatry · doi:10.1002/0470854871.chxix1 · Cited by 101
Self-citationBeckett, S. R. G., Lawrence, A. J., Marsden, C. A., & Marshall, P. W. (1992) · Psychopharmacology · doi:10.1007/bf02245294 · Cited by 101
Sena, L. M., Bueno, C. H., Pobbe, R. L. H., Andrade, T. G. C. S., Zangrossi, H., & Viana, M. D. B. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00399-6 · Cited by 98
Sinha, S. S., Coplan, J. D., Gorman, J., Pine, D. S., Martínez, J. A. B., & Klein, D. F. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00029-3 · Cited by 94
Rydin, E., Schalling, D., & Åsberg, M. (1982) · Psychiatry Research · doi:10.1016/0165-1781(92)90096-l · Cited by 93
Lovick, T. A. (2000) · The Neuroscientist · doi:10.1177/107385840000600113 · Cited by 91
Zanoveli, J. M., Nogueira, R. L., & Zangrossi, H. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01970-8 · Cited by 89
Bell, C., Forshall, S. W., Adrover, M., Nash, J. R., Hood, S. D., Argyropoulos, S. V., Rich, A. S., & Nutt, D. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600116 · Cited by 86
Canteras, N. S., Ribeiro-Barbosa, É. R., & Comoli, E. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00048-3 · Cited by 86
Effect of metergoline on human anxiety
Graeff, F. G., Zuardi, A. W., Giglio, J. S., Filho, E. C. L., & Karniol, I. G. (1985) · Psychopharmacology · doi:10.1007/bf00432224 · Cited by 85
Self-citationZangrossi, H., Viana, M. D. B., & Graeff, F. G. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00075-8 · Cited by 83
Self-citationMaier, S. F., Kalman, B. A., & Grahn, R. E. (1994) · Behavioral Neuroscience · doi:10.1037//0735-7044.108.1.121 · Cited by 74
Johnson, M., Lydiard, R. B., & Ballenger, J. C. (1995) · Drugs · doi:10.2165/00003495-199549030-00002 · Cited by 74
Anatomic and pharmacologic differences between two types of aversive midbrain stimulation
Kiser, R. S., Lebovitz, R. M., & German, D. C. (1978) · Brain Research · doi:10.1016/0006-8993(78)91026-0 · Cited by 74
Viana, M. D. B., Graeff, F. G., & Löschmann, P. A. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00451-0 · Cited by 74
Self-citationChen, A., Hough, C. J., & Li, H. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00076-9 · Cited by 72
Silveira, M. C. L., Zangrossi, H., Viana, M. D. B., Silveira, R., & Graeff, F. G. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00233-9 · Cited by 71
Self-citationDorsal raphe nucleus stimulation reduces centrally-elicited fearlike behavior
Kiser, R. S., Brown, C. A., Sanghera, M. K., & German, D. C. (1980) · Brain Research · doi:10.1016/0006-8993(80)90331-5 · Cited by 70
Pharmacology of human experimental anxiety
Graeff, F. G., Parente, A., Del-Ben, C. M., & Guimarães, F. S. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003000400003 · Cited by 70 · cited 2×
“[54] Graeff FG, Parente A, Del-Ben CM, Guimarães FS.”
BackgroundSelf-citationDecreased left temporal lobe volume of panic patients measured by magnetic resonance imaging
Uchida, R. R., Del‐Ben, C. M., dos Santos, A. C., Araújo, D., Crippa, J. A. S., Guimarães, F. S., & Graeff, F. G. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003000700014 · Cited by 70
Self-citationBrain correlates of an unexpected panic attack: a human positron emission tomographic study
Fischer, H., Andersson, J., Furmark, T., & Fredrikson, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00503-5 · Cited by 69
A neuropharmacological study of the periventricular neural substrate involved in flight
Schmitt, P., Carrive, P., Scala, G. D., Jenck, F., Brandão, M. L., Bagri, A., Moreau, J., & Sandner, G. (1986) · Behavioural Brain Research · doi:10.1016/0166-4328(86)90039-2 · Cited by 68
d -Fenfluramine in panic disorder: a dual role for 5-hydroxytryptamine
Mortimore, C., & Anderson, I. M. (2000) · Psychopharmacology · doi:10.1007/s002139900342 · Cited by 68
Beckett, S. R. G., & Marsden, C. A. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100111 · Cited by 64
Keim, S. R., & Shekhar, A. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00810-4 · Cited by 63
Serotonergic reduction of dorsal central gray area stimulation-produced aversion
Kiser, R. S., German, D. C., & Lebovitz, R. M. (1978) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(78)90008-4 · Cited by 63
Controlling panic attacks with fenfluramine
Solyom, L. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.4.621b · Cited by 61
(1987) · Cited by 60
Anxiolytic-like effects of median raphe nucleus lesion in the elevated T-maze
Andrade, T. G. C. S., de Macedo, C. E. A., Zangrossi, H., & Graeff, F. G. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.10.036 · Cited by 60
Self-citationDorsal periaqueductal gray punishment, septal lesions and the mode of action of minor tranquilizers
Graeff, F. G., & Rawlins, J. N. P. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90413-x · Cited by 59
Self-citationNormative data for the personal report of confidence as a speaker
Phillips, G. C., Jones, G. E., Rieger, E. J., & Snell, J. B. (1997) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(97)00007-8 · Cited by 57
Sewards, T. V., & Sewards, M. A. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00020-9 · Cited by 57
Vargas, L. C., & Schenberg, L. C. (2001) · Psychopharmacology · doi:10.1007/s002130100698 · Cited by 56
Jenck, F., Broekkamp, C. L. E., & Delft, A. M. L. V. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90847-9 · Cited by 55
Maier, S. F., Kalman, B. A., & Grahn, R. E. (1994) · Behavioral Neuroscience · doi:10.1037/0735-7044.108.1.121 · Cited by 55
A model of panic and agoraphobic development
Klein, D. F., & Gorman, J. M. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb07753.x · Cited by 54
Jacob, C., Cabral, A. H. C. L., de Almeida, L. P., Magierek, V., Ramos, P. L., Zanoveli, J. M., Landeira-Fernández, J., Zangrossi, H., & Nogueira, R. L. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00785-7 · Cited by 53
Guimarães, F. S., Hellewell, J. S. E., Hensman, R., Wang, M., & Deakin, J. F. W. (1991) · Psychopharmacology · doi:10.1007/bf02244184 · Cited by 48
Magierek, V., Ramos, P. L., da Silveira-Filho, N. G., Nogueira, R. L., & Landeira-Fernández, J. (2003) · Neuroreport · doi:10.1097/00001756-200308260-00020 · Cited by 46
Effect of d -fenfluramine on human experimental anxiety
Hetem, L. A. B., de Souza, C. J., Guimarães, F. S., Zuardi, A. W., & Graeff, F. G. (1996) · Psychopharmacology · doi:10.1007/s002130050086 · Cited by 45
Self-citationGentil, V., Neto, F. L., Andrade, L. H., Córdas, T. A., Bernik, M., Ramos, R. T., Maciel, L., Miyakawa, E., & Gorenstein, C. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700402 · Cited by 44
DeCarvalho, S., DEAGUIAR, J., & Graeff, F. G. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90261-6 · Cited by 44
Self-citationDel‐Ben, C. M., Vilela, J. A. A., Hetem, L. A. B., Guimarães, F. S., Graeff, F. G., & Zuardi, A. W. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00312-2 · Cited by 43
Self-citationAudi, E. A., de Oliveira, R. M. W., & Graeff, F. G. (1991) · Psychopharmacology · doi:10.1007/bf02244379 · Cited by 41
Self-citationRitanserin facilitates anxiety in a simulated public-speaking paradigm
Guimarães, F. S., Mbaya, P. Y., & Deakin, J. F. W. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100305 · Cited by 41
Opposite effects of nefazodone in two human models of anxiety
Silva, M., Hetem, L. A. B., Guimarães, F. S., & Graeff, F. G. (2001) · Psychopharmacology · doi:10.1007/s002130100752 · Cited by 40
Self-citationEnhancement of CO2-Induced Anxiety in Healthy Volunteers With the Serotonin Antagonist Metergoline
Ben-Zion, I., Meiri, G., Greenberg, B. D., Murphy, D. L., & Benjamin, J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.10.1635 · Cited by 36
The effect of antidepressants on aversive periaqueductal gray stimulation in rats
Jenck, F., Broekkamp, C. L. E., & Delft, A. M. L. V. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90271-7 · Cited by 33
5-HT mediation of the antiaversive effect of isamoltane injected into the dorsal periaqueductal grey
Nogueira, R. L., & Graeff, F. G. (1991) · Behavioural Pharmacology · doi:10.1097/00008877-199102000-00010 · Cited by 32
Self-citationVulnerability and conditioning in relation to the human menstrual cycle
Vila, J., & Beech, H. R. (1977) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1977.tb01004.x · Cited by 31
Palma, S. M. M., Guimarães, F. S., & Zuardi, A. W. (1994) · PubMed · Cited by 28
Hetem, L. A. B. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199602000-00014 · Cited by 24
Jones, B. J., Paterson, I. A., & Roberts, M. H. T. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90216-9 · Cited by 19
Snyder, S. H. (2002) · Nature · doi:10.1038/416377a · Cited by 17
Graeff, F. G., Silva, M., Del‐Ben, C. M., Zuardi, A. W., Hetem, L. A. B., & Guimarães, F. S. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00055-0 · Cited by 15
Self-citationD-fenfluramine selectively releases 5-HT from dorsal raphe terminals.
Viana, M. D. B., Silveira, R., & Graeff, F. G. (1996) · PubMed · Cited by 11
Self-citationWang, M. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb10552.x · Cited by 7
Guest editorial: Towards an integrated model for panic disorder
Gentil, V. (1988) · Stress Medicine · doi:10.1002/smi.2460040302 · Cited by 5
Fisiopatologia da sindrome do panico
Gentil, V. (1986) · Revista da Associação Médica Brasileira · Cited by 5
Júnior, A. S., & Córdas, T. A. (2001) · RBM. Revista brasileira de medicina · Cited by 3
Zangrossi, H., & Pobbe, R. L. H. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)92130-4 · Cited by 1
Research works printed but not linked: 10
- Andrade, 2000, Role of the median raphe nucleus in the modulation of two types of fear/anxiety responses in rats submitted to the elevated T-maze, J Psychopharmacol, 14, A38
- Freud, 1959, Inhibition, symptoms and anxiety, vol. 20
- Gentil, 1988, The aversive system, 5HT and panic attacks, vol. 1, 142
- Graeff, 1988, Animal models of aversion, vol. 1, 115
- Graeff, 1990, Brain defense systems and anxiety, vol. 3, 307
- Kennett, 1993, 5-HT1C receptors and their therapeutic relevance, Curr Opin Invest Drugs, 2, 317
- Leal, 2003, Simulated public speaking did not activate the hypothalamic-pituitary-adrenal axis in neither panic patients or healthy controls, J Psychopharmacol, 17, A24/A79
- Nashold, 1974, The midbrain and pain, vol. 4, 191
- Petersen, 1984, Anticonflict effects of 5-HT antagonists by intraamygdaloid injection, Abstr 14th CINP Cong, 654
- Vargas, 2001, Pharmacological and endocrinological properties of intracranially-induced panic-like behaviors, Soc Neurosci Abstr, 27, 858.11
Cited by
Sorted by citations
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893
When fear is near: threat imminence elicits prefrontal periaqueductal gray shifts in humans.
Mobbs, D., Petrovic, P., Marchant, J. L., Hassabis, D., Weiskopf, N., Seymour, B., Dolan, R. J., & Frith, C. D. (2007) · Science · doi:10.1126/science.1144298 · Cited by 951
Adolphs, R. (2013) · Current Biology · doi:10.1016/j.cub.2012.11.055 · Cited by 524
From threat to fear: the neural organization of defensive fear systems in humans.
Mobbs, D., Marchant, J. L., Hassabis, D., Seymour, B., Tan, G., Gray, M., Petrovic, P., Dolan, R. J., & Frith, C. D. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2378-09.2009 · Cited by 476
Opponency revisited: competition and cooperation between dopamine and serotonin
Boureau, Y.-L., & Dayan, P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.151 · Cited by 456
Metadata
- Authors
- Graeff, F. G.
- Affiliations
- Universidade de São Paulo (BR)
- Corresponding author
- Graeff, Frederico G
- ORCID
- Graeff, Frederico G
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 28
- Issue
- 3
- Pages
- 239-259
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2143184913
- Cited by
- 285
- References
- 144
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 9 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 3 · 2019: 9 · 2018: 7 · 2017: 12 · 2016: 5 · 2015: 19 · 2014: 15 · 2013: 18 · 2012: 17
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience & Biobehavioral Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Keywords
- serotonin, periaqueductal gray, panic disorder, defensive behavior, anxiety, elevated T-maze, conditioned anxiety, unconditioned fear, anxiolytic effects, generalized anxiety disorder
- MeSH terms
- Animals, Anxiety, Brain Mapping, Conflict, Psychological, Escape Reaction, Humans, Models, Psychological, Periaqueductal Gray, Serotonin, Panic Disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review